Jump to content

International Federation of Pharmaceutical Manufacturers & Associations

From Wikipedia, the free encyclopedia
International Federation of Pharmaceutical Manufacturers & Associations
AbbreviationIFPMA
Formation1968
TypeTrade association
HeadquartersGeneva, Switzerland
President
Albert Bourla[1]
Key people
Albert Bourla (chairman, president and CEO)
Dr Thomas Schinecker (Vice President)
Websitehttps://www.ifpma.org/

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)[2] is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations[3] where it contributes industry expertise to global health discussions.

It was formed in 1968 and is based in Geneva, Switzerland.[4]

In 2019, IFPMA released a strengthened code of ethics[5] and professional standards.[6] Among the revisions to the code is a prohibition on gifts provided to healthcare professionals.[7] The code revision has been followed by Ethoscope[8] – an open-source, continuously evolving resource that contains diverse guidance designed to keep pace with emerging developments.

The pharmaceutical industry contributes to the Sustainable Development Goals (SDGs), in particular Goal 3 to ensure healthy lives and promote well-being for all at all ages.[9] Today over 35 IFPMA member companies contribute resources and knowhow to SDG initiatives [10] partnering with academia, development organizations, NGOs, foundations and other business sectors. There are over 250 collaborations that aim to strengthen health systems and expand quality healthcare access.[11]

IFPMA works in partnership with other members of the global health community to achieve Universal Health Coverage (UHC) targets and contribute to a world where no one is left behind in receiving the healthcare they need.[12] A wide range of stakeholders across the public and private sectors have an opportunity to collaborate more closely to increase affordability of and access to essential medicines, and the low-cost, but highly effective, interventions and screenings.[13]

Leadership

[edit]

Since 2022, Dr Albert Bourla, chairman and CEO of Pfizer has served as President and Dr Thomas Schinecker, CEO of Roche serves as Vice-President.

In November 2024, IFPMA announced that Thomas Schinecker would replace Albert Bourla as President. Robert M. Davis, CEO of Merck & Co., and Dr Sunao Manabe, CEO of Daiichi Sankyo, will serve as Vice-Presidents.[14]

See also

[edit]

References

[edit]
  1. ^ CEOs from Pfizer, Roche, and Daiichi Sankyo take up roles on IFPMA CEO leadership team,IFPMA,12 July 2023, [1]
  2. ^ "International Federation of Pharmaceutical Manufacturers & Associations - IFPMA". Retrieved 2 November 2023.
  3. ^ "List of NGOs accredited at the UN Office at Geneva". Retrieved 7 December 2022.
  4. ^ "About IFPMA". Archived from the original on 26 June 2014. Retrieved 11 Jun 2014.
  5. ^ "New International Pharmaceutical Practice Code Tightens Restrictions on Gifts". Ropes & Gray. 27 February 2019. Retrieved 30 October 2023.
  6. ^ Underwood, George (18 Mar 2020). "Industry and patient groups collaborate on new guidance for interaction". Retrieved 7 December 2022.
  7. ^ Baker, Berry (20 December 2018). "IFPMA launches new Code of Practice for the pharmaceutical industry". Pharma Technology. Retrieved 30 October 2023.
  8. ^ Lugogo, Mwana (24 April 2023). "Industry and patient groups collaborate on new guidance for interaction". PharmaBoardroom. Retrieved 30 October 2023.
  9. ^ "Goal 3: Ensure healthy lives and promote well-being for all at all ages". United Nations. Retrieved 30 October 2023.
  10. ^ Explore Collaborations Global Health Progress 2023,https://globalhealthprogress.org/explore-our-collaborations/
  11. ^ "Global Health Progress is an interactive resource hub highlighting collaborations between the innovative biopharmaceutical industry and our partners to support the SDGs". 18 Mar 2022. Retrieved 7 December 2022.
  12. ^ "Private Sector Commitments To Universal Health Coverage, UHC2030 Private Sector Constituency 2023 Statement" (PDF). UHC2030. Retrieved 30 October 2023.
  13. ^ "The Road to 2030: Revitalizing Multi-sectoral Partnerships to Achieve Universal Health Coverage". Foreign Policy Analytics. Retrieved 30 October 2023.
  14. ^ "Roche CEO named as new president of IFPMA". www.thepharmaletter.com. Retrieved 2024-11-27.
  15. ^ EFPIA, https://www.ifpma.org/members/efpia/
  16. ^ Interpharma, https://www.ifpma.org/members/interpharma/
  17. ^ IPASA, https://www.ifpma.org/members/ipasa/
  18. ^ JPMA, https://www.ifpma.org/members/jpma/
  19. ^ LEEM, https://www.ifpma.org/members/leem/
[edit]
Retrieved from "https://wiki.riteme.site/w/index.php?title=International_Federation_of_Pharmaceutical_Manufacturers_%26_Associations&oldid=1259856181"